Loading...

Distinct HIV-1 Neutralization Potency Profiles of Ibalizumab-Based Bispecific Antibodies

BACKGROUND: Pre-exposure prophylaxis (PrEP) using antiretroviral (ARV) agents has been shown to effectively prevent human immunodeficiency virus type 1 (HIV-1) acquisition in high-risk populations. However, the efficacy of these regimens is highly variable, which is thought to be largely due to the...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Acquir Immune Defic Syndr
Main Authors: Song, Ruijiang, Pace, Craig, Seaman, Michael S., Fang, Qing, Sun, Ming, Andrews, Chasity D., Wu, Amos, Padte, Neal N., Ho, David D.
Format: Artigo
Sprog:Inglês
Udgivet: 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5123706/
https://ncbi.nlm.nih.gov/pubmed/27792681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000001119
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!